Open label trial of Faldaprevir and BI 207127 versus Telaprevir

• Research type

  Research Study

• Full title

  A phase III, randomised, open label, active-controlled study of an interferon-free regimen of BI 207127 in combination with Faldaprevir and Ribavirin compared to Telaprevir in combination with pegylated interferon-a and ribavirin in treatment-naïve patients with chronic genotype 1b Hepatitis C Virus infection

• IRAS ID

  123986

• Contact name

  Daniel Forton

• Contact email

  daniel.forton@nhs.net

• Eudract number

  2012-004544-30

• ISRCTN Number

  n/a

• Clinicaltrials.gov Identifier

  n/a

• REC name

  South Central - Oxford C Research Ethics Committee

• REC reference

  13/SC/0146

• Date of REC Opinion

  8 May 2013

• REC opinion

  Further Information Favourable Opinion